TY - JOUR
T1 - Disturbed Sleep is Not Good for the Heart
T2 - A Narrative Review
AU - Patel, Meet
AU - Yarlagadda, Harshani
AU - Upadhyay, Shubekshya
AU - Neupane, Ritesh
AU - Qureshi, Umer
AU - Raco, Joseph D.
AU - Jain, Rahul
AU - Jain, Rohit
N1 - Publisher Copyright:
©2023 Bentham Science Publishers.
PY - 2023
Y1 - 2023
N2 - Sleep-related breathing disorders, including obstructive sleep apnea (OSA) and central sleep apnea (CSA), have a major impact on cardiovascular function. It has shown an association with hypertension, coronary artery disease, cardiac arrhythmias, sudden cardiac death, and congestive heart failure (CHF). This review focuses on highlighting the relationship between sleep apnea and CHF. We discuss the underlying pathophysiology, which involves the mechanical, neurohor-monal, and inflammatory mechanisms; in addition, the similarities and differentiating clinical features of OSA in patients with CHF and without CHF. We have also discussed several treatment strategies, including weight loss, continuous positive airway pressure (CPAP), supplemental oxygen therapy, theophylline, acetazolamide, mandibular advancement device, and hypoglossal nerve stimulation (HGNS). We conclude that since there are several overlapping clinical features in patients with OSA with Heart Failure (HF) and without HF, early detection and treatment are crucial to decrease the risk of HF, coronary artery disease, and stroke.
AB - Sleep-related breathing disorders, including obstructive sleep apnea (OSA) and central sleep apnea (CSA), have a major impact on cardiovascular function. It has shown an association with hypertension, coronary artery disease, cardiac arrhythmias, sudden cardiac death, and congestive heart failure (CHF). This review focuses on highlighting the relationship between sleep apnea and CHF. We discuss the underlying pathophysiology, which involves the mechanical, neurohor-monal, and inflammatory mechanisms; in addition, the similarities and differentiating clinical features of OSA in patients with CHF and without CHF. We have also discussed several treatment strategies, including weight loss, continuous positive airway pressure (CPAP), supplemental oxygen therapy, theophylline, acetazolamide, mandibular advancement device, and hypoglossal nerve stimulation (HGNS). We conclude that since there are several overlapping clinical features in patients with OSA with Heart Failure (HF) and without HF, early detection and treatment are crucial to decrease the risk of HF, coronary artery disease, and stroke.
UR - http://www.scopus.com/inward/record.url?scp=85152165898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152165898&partnerID=8YFLogxK
U2 - 10.2174/1573403X19666221130100141
DO - 10.2174/1573403X19666221130100141
M3 - Review article
C2 - 36453501
AN - SCOPUS:85152165898
SN - 1573-403X
VL - 19
JO - Current Cardiology Reviews
JF - Current Cardiology Reviews
IS - 3
M1 - e301122211378
ER -